Skip to content

The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03525847
Enrollment
150
Registered
2018-05-16
Start date
2017-01-01
Completion date
2020-01-01
Last updated
2022-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic Ultrasonography

Keywords

Contrast endosonograpy

Brief summary

A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy

Detailed description

A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors

Interventions

DIAGNOSTIC_TESTEndosonography

Puncture of the pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. Passage in the same pancreatic mass of first using standard FNA method then contrast enhanced FNA method or vice versa according to the randomization

Sponsors

Professor Dr. Seicean Andrada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 86 Years
Healthy volunteers
No

Inclusion criteria

* solid pancreatic tumor lesions

Exclusion criteria

* severe coagulopathy of trombocytopenia \<50.000 * patients refuse for biopsy prelevation or pacient's refuse to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methodsan average of 2 yearsDiagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods

Secondary

MeasureTime frameDescription
Comparison between standand endosonography and contrast enhanced endosonography in obtaining a superior quality in obtaining histology coreday oneVisual analogic scale
Quality of histological specimen(histology core) obtained with the two types of FNA biopsies (contrast enhanced and standard)5 daysVisual analogic scale
Dysfunction in the two types of biopsiesday onefailure or difficulty reports with each procedure (%)

Countries

Romania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026